文献类型： 外文期刊

作者： Li, Jizong ¹ ; Xiao, Li ¹ ; Chen, Zhuoqi ¹ ; Fan, Liyuan ¹ ; Wang, Wei ¹ ; Guo, Rongli ¹ ; He, Zhaoming ⁷ ; Hu, Hongpeng ⁷ ; Jiang, Jianhao ⁷ ; Zhao, Lixiang ⁷ ; Zhong, Tianyi ⁷ ; Fan, Baochao ¹ ; Zhu, Xing ⁶ ; Li, Bin ¹ ;

作者机构： 1.Jiangsu Acad Agr Sci, Inst Vet Med, Key Lab Vet Biol Engn & Technol, Jiangsu Key Lab Food Qual & Safety,Minist Agr,Stat, Nanjing, Peoples R China

2.Jiangsu Univ, Inst Life Sci, Sch Food & Biol Engn, Zhenjiang, Peoples R China

3.Nanjing Agr Univ, Coll Vet Med, Nanjing, Peoples R China

4.Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China

5.Guotai Taizhou Ctr Technol Innovat Vet Biol, Taizhou, Peoples R China

6.Guizhou Univ, Coll Anim Sci, Guiyang, Peoples R China

7.Suzhou Huiliao Biomed Technol Co Ltd, Suzhou, Peoples R China

关键词： PDCoV; mRNA vaccine; spike protein; lipid nanoparticle; suckling piglets

期刊名称：JOURNAL OF VIROLOGY （ 影响因子：4.0； 五年影响因子：4.0 ）

ISSN： 0022-538X

年卷期： 2024 年

页码：

收录情况： SCI

摘要： Coronaviruses (CoVs) are important pathogens for humans and other vertebrates, causing severe respiratory and intestinal infections that have become a threat to public health because of the potential for interspecies transmission between animals and humans. Therefore, the development of safe, effective vaccines remains a top priority for the control of CoV infection. The unique immunological characteristics of vaccines featuring messenger RNA (mRNA) present an advantageous tool for coronavirus vaccine development. Here, we designed two lipid nanoparticle (LNP)-encapsulated mRNA (mRNA-LNP) vaccines: one encoding full-length spike (S) protein and the other encoding the spike ectodomain (Se) from porcine deltacoronavirus (PDCoV). Fourteen days after primary immunization, both mRNA vaccines induced high levels of immunoglobulin G and neutralizing antibodies in mice, with the S vaccine showing better performance than the Se vaccine. Passive immune protection of the S mRNA vaccine in suckling piglets was confirmed by the induction of robust PDCoV-specific humoral and cellular immune responses. The S mRNA vaccine also showed better protective effects than the inactivated vaccine. Our results suggest that the novel PDCoV-S mRNA-LNP vaccine may have the potential to combat PDCoV infection.IMPORTANCEAs an emerging porcine enteropathogenic coronavirus, porcine deltacoronavirus (PDCoV) has the potential for cross-species transmission, attracting extensive attention. Messenger RNA (mRNA) vaccines are a promising option for combating emerging and re-emerging infectious diseases, as evidenced by the demonstrated efficacy of the COVID-19 mRNA vaccine. Here, we first demonstrated that PDCoV-S mRNA-lipid nanoparticle (LNP) vaccines could induce potent humoral and cellular immune responses in mice. An evaluation of passive immune protection of S mRNA vaccines in suckling piglets confirmed that the protective effect of mRNA vaccine was better than that of inactivated vaccine. This study suggests that the PDCoV-S mRNA-LNP vaccine may serve as a potential and novel vaccine candidate for combating PDCoV infection. As an emerging porcine enteropathogenic coronavirus, porcine deltacoronavirus (PDCoV) has the potential for cross-species transmission, attracting extensive attention. Messenger RNA (mRNA) vaccines are a promising option for combating emerging and re-emerging infectious diseases, as evidenced by the demonstrated efficacy of the COVID-19 mRNA vaccine. Here, we first demonstrated that PDCoV-S mRNA-lipid nanoparticle (LNP) vaccines could induce potent humoral and cellular immune responses in mice. An evaluation of passive immune protection of S mRNA vaccines in suckling piglets confirmed that the protective effect of mRNA vaccine was better than that of inactivated vaccine. This study suggests that the PDCoV-S mRNA-LNP vaccine may serve as a potential and novel vaccine candidate for combating PDCoV infection.